Semantic Scholar uses AI to extract papers important to this topic.
Few therapeutic options are available to treat the late-stage of human African trypanosomiasis, a neglected tropical… Expand BACKGROUND
Existing diagnostic and treatment tools for human African trypanosomiasis (HAT) are limited. The recent development of… Expand Abstract Despite the recent advances in drug research, finding a safe, effective, and easy to use chemotherapy for human African… Expand Graphical abstract Genome-scale RNA interference (RNAi) library screens in bloodstream-form Trypanosoma brucei, using nifurtimox… Expand Human African trypanosomiasis or 'sleeping sickness' is a neglected tropical disease caused by the parasite Trypanosoma brucei. A… Expand ABSTRACT The success of nifurtimox-eflornithine combination therapy (NECT) for the treatment of human African trypanosomiasis… Expand SUMMARY For over fifty years, human African trypanosomiasis (HAT, sleeping sickness) has been treated with suramin, pentamidine… Expand Fatal if untreated, human African trypanosomiasis (HAT; sleeping sickness) afflicts an estimated 50,000–70,000 people each year… Expand BACKGROUND
Human African trypanosomiasis (HAT; sleeping sickness) caused by Trypanosoma brucei gambiense is a fatal disease… Expand BACKGROUND
Human African trypanosomiasis caused by Trypanosoma brucei gambiense is a fatal disease. Current treatment options for… Expand